World News: 11:00 GMT Friday 2nd August 2019. [CytoDyn Inc. via Globe Newswire via SPi World News]
VANCOUVER Washington Aug 02 2019 GLOBE NEWSWIRE --or the Company a late stage biotechnology company developing leronlimab PRO 140 a CCR5 antagonist with the for multiple therapeutic indications today a nnounce...
Globe Newswire: 11:00 GMT Friday 2nd August 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.